26847-01-8 Usage
General Description
2-Chloro-4-methyl-thiazole is a chemical compound with the molecular formula C4H4ClNS. It is a colorless to pale yellow liquid with a pungent odor, and it is mainly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and dyes. 2-CHLORO-4-METHYL-THIAZOLE is also used in the preparation of flavors and fragrances. In terms of safety, 2-chloro-4-methyl-thiazole may cause skin and eye irritation, and it should be handled with proper protective measures in place. Additionally, it is important to store and dispose of this chemical in compliance with local regulations to mitigate any potential environmental and health hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 26847-01-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,8,4 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 26847-01:
(7*2)+(6*6)+(5*8)+(4*4)+(3*7)+(2*0)+(1*1)=128
128 % 10 = 8
So 26847-01-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H4ClNS/c1-3-2-7-4(5)6-3/h2H,1H3
26847-01-8Relevant articles and documents
Substituted 1-propiolylpiperazine compounds, their preparation and use
-
, (2008/06/13)
Substituted 1-propiolylpiperazine compounds corresponding to formula I in which X denotes N or C—R2, and n is an integer from 0 to 8, a method for producing such substituted 1-propiolylpiperazine compounds, pharmaceutical compositions containing such substituted 1-propiolylpiperazine compounds, and the use of such substituted 1-propiolylpiperazine compounds for modulating mGluR5 receptor activity or for treating or inhibiting pain and various other conditions, especially conditions at least partly mediated by the mGluR5 receptor.
Acetylenyl-pyrazolo-pyrimidine derivatives
-
Page/Page column 28-29, (2008/06/13)
The present invention relates to compounds of formula (I): wherein R1 to R3, A, M, L, E, G, and J are as defined in the description and claims. The invention also relates to a process for the manufacture of such compounds, pharmaceutical compositions containing them, and methods for treating CNS disorders.